NEW YORK--(BUSINESS WIRE)--Jul 22, 2025-- Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO): (i) pursuant and/or traceable to Alto’s initial public offering conducted on or about February 2, 2024 (the “IPO”); and/or (ii) securities between February 2, 2024 and October 22, 2024. Alto describes itself as a “clinical-stage biopharmaceutical company in the U.S.” For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Alto Neuroscience, Inc. (NYSE: ANRO) Misled Investors Regarding its Business Operations.